Avanos Medical Inc (AVNS) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Avanos Medical Inc   (NYSE: AVNS)
 

Avanos Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Avanos Medical Inc inventory turnover ratio, the Avanos Medical Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 2.44 in the first quarter 2026, yet the ratio remained below the average, as AVNS's market remain challenging.Average inventory processing period, for the Avanos Medical Inc in Mar 31 2026 quarter, has decreased to 150 days, compare to 153 days, in the Dec 31 2025 quarter.

Within Healthcare sector 157 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 453, from total ranking in the fourth quarter 2025 at 585.

AVNS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Avanos Medical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVNS Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 2.32 % 6.63 % -6.98 % -12.93 % -16.61 %
Y / Y Cost of Sales Growth 14.29 % 16.3 % 18.18 % 7.89 % 8.45 %
Inventory Turnover Ratio (TTM) 2.44 2.38 2.33 2.18 2.07
AVNS's Total Ranking # 453 # 585 # 570 # 702 # 702
Average inventory processing period 149 153 157 167 176
Seq. Inventory Growth -4.53 % -1.73 % 5.54 % 3.33 % -0.5 %
Seq. Cost of Sales Growth -7.27 % 4.29 % 10.98 % 6.49 % -5.64 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 63
Healthcare Sector # 158
Overall Market # 453

Inventory Turnover Ratio Statistics
High Average Low
6.85 2.81 1.73
(Sep 30 2015)   (Sep 30 2024)



AVNS Company Profile >> Back to AVNS Efficiency Comparisons >> Compare AVNS Inventory Turnover Ratio to its Competitors

Financial Statements
Avanos Medical Inc 's Inventories $ 141 Millions Visit AVNS's Balance sheet
Avanos Medical Inc 's Cost of Revenues TTM $ 356 Millions Visit AVNS's Income Statement
What are AVNS's Sales? Visit AVNS's Sales by Segment

Other Inventory Turnover Ratios
Avanos Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AVNS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AVNS's Competitors
Inventory Turnover Ratio for AVNS's Suppliers
Inventory Turnover Ratio for AVNS's Customers

You may also want to know
AVNS's Sales Growth Rates AVNS's Pe Price to earnings ratio AVNS's Receivables Turnover Ratio AVNS's Stock Quote
AVNS's Net Income Growth Rates AVNS's Ps Price to Sales ratio AVNS's Sales per Employee AVNS's Asset Turnover Ratio
AVNS's Net Margin AVNS's Pb Price to Book ratio AVNS's Financial Strength Ratios AVNS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions

Date modified: 2026-08-30T14:42:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.